<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is the most common <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> in clinical practice </plain></SENT>
<SENT sid="1" pm="."><plain>Systemic inflammatory state, <z:mp ids='MP_0003674'>oxidative stress</z:mp> injury, and atrial <z:mp ids='MP_0003045'>fibrosis</z:mp> are identified as the main mechanisms for AF </plain></SENT>
<SENT sid="2" pm="."><plain>Considering the multifactorial mechanisms of AF, a novel therapeutic agent with multi-bioactivities should be presented </plain></SENT>
<SENT sid="3" pm="."><plain>Regular consumption of green tea has been associated with a reduced risk of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> and against a large number of pathologic conditions </plain></SENT>
<SENT sid="4" pm="."><plain>Recent results indicate that green tea extract, especially <z:chebi fb="0" ids="4806">(-)-epigallocatechin-3-gallate</z:chebi>, could effectively decrease inflammatory factors secretion, antagonize oxidation, and inhibit matrix metalloproteinase activities </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibition of <z:mp ids='MP_0001845'>inflammation</z:mp>, modulation of <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and targeting tissue <z:mp ids='MP_0003045'>fibrosis</z:mp> represent new approaches in tackling AF; therefore, green tea may be an innovative therapeutic candidate to prevent the occurrence, maintenance, and recurrence of AF </plain></SENT>
</text></document>